Please sign in to follow a disease.
ICU alarm overload: new protocol aims to cut noise and save lives
NCT ID NCT06175091
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new way to manage alarms in intensive care units (ICUs). Currently, patients trigger hundreds of alarms daily, most of which are false or unimportant. The researchers will compare standard alarm management (left to nurses) with a stricter protocol that limits alarms. They will measure how many alarms go off and how long patients have dangerous vital signs, aiming to reduce noise and improve safety. About 514 ICU patients will take part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- alarm management protocol (restrictive vs. standard)
- What this could lead to
- If successful, this could lead to quieter ICUs and fewer false alarms, potentially improving patient safety and comfort.
- What could go wrong
- This is an early-stage study focused on process, not a new drug or cure. Results may not apply to other hospitals, and reducing alarms could risk missing real emergencies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 514 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2024
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient aged ≥ 18 years * Patient admitted to the intensive care unit of the ST-ETIENNE University Hospital * Patient affiliated or entitled to a social security system * Patient having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study or, for patients who are unable to consent due to health condition, a trusted person/family member who has been informed about the study and has who has co-signed, with the investigator, a consent to participate Exclusion Criteria: * Pregnant and nursing women * Persons of legal age under guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intensive care unit are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Saint-Etienne
RECRUITINGSaint-Etienne, 42055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict superbug evolution in the ICU?
- Could albumin boost oxygen delivery in sepsis? new trial investigates
- Life after a seizure emergency: study tracks hidden toll on mind and body
- Could a vitamin B12 derivative help treat shock?
- Ultrasound vs. blind stick: which works better for ICU artery access?
- ICU suction procedure questioned: new study looks at lung effects